Emergence of erosive polyarthritis coincident with Mycobacterium kansassi pulmonary infection in a patient with systemic sclerosis-rheumatoid arthritis overlap syndrome.
Iwata
H
H
Kinoshita
M
M
Sumiya
M
M
Iwai
A
A
Aotsuka
S
S
Hirata
D
D
Minota
S
S
D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D001426:Bacterial Proteins; D018834:Chaperonin 60; D018833:Chaperonins / Q000276:immunology; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D019909:Mycobacterium kansasii / Q000302:isolation & purification*; D012217:Rheumatoid Factor / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D013577:Syndrome; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000150:complications* / Q000188:drug therapy
D000995:Antitubercular Agents; D001426:Bacterial Proteins; D018834:Chaperonin 60; D007075:Immunoglobulin M; C074119:heat-shock protein 65, Mycobacterium; D012217:Rheumatoid Factor; D018833:Chaperonins